Myszkowski Kenneth Allen has filed 10 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 100000 shares of ARROWHEAD PHARMACEUTICALS, INC. ($ARWR) on January 04, 2025.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 4, 2025 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Myszkowski Kenneth Allen | Chief Financial Officer | A | Common Stock | 100000 | $0.00 | 500,600.0000 | 124,848,000 | 24.96% | 0.08% |
| Jan. 6, 2025 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 17765 | $19.68 | 482,835.0000 | 124,848,000 | 3.55% | 0.01% |
| Jan. 6, 2025 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 9402 | $20.10 | 473,433.0000 | 124,848,000 | 1.95% | 0.01% |
| Jan. 7, 2025 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 8000 | $19.70 | 465,433.0000 | 124,848,000 | 1.69% | 0.01% |
| Jan. 7, 2025 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 10000 | $19.69 | 455,433.0000 | 124,848,000 | 2.15% | 0.01% |
| March 6, 2024 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 40000 | $35.19 | 400,600.0000 | 106,750,000 | 9.08% | 0.04% |
| Jan. 4, 2024 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Myszkowski Kenneth Allen | Chief Financial Officer | A | Common Stock | 75000 | $0.00 | 456,704.0000 | 106,750,000 | 19.65% | 0.07% |
| Jan. 5, 2024 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 1400 | $34.04 | 455,304.0000 | 106,750,000 | 0.31% | 0.00% |
| Jan. 5, 2024 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 5800 | $34.97 | 449,504.0000 | 106,750,000 | 1.27% | 0.01% |
| Jan. 5, 2024 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 8904 | $35.65 | 440,600.0000 | 106,750,000 | 1.98% | 0.01% |